Global Non-Invasive Prenatal Screening (NIPS) Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Non-Invasive Prenatal Screening (NIPS) will have significant change from previous year. According to our (LP Information) latest study, the global Non-Invasive Prenatal Screening (NIPS) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-Invasive Prenatal Screening (NIPS) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Non-Invasive Prenatal Screening (NIPS) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Non-Invasive Prenatal Screening (NIPS) market, reaching US$ million by the year 2028. As for the Europe Non-Invasive Prenatal Screening (NIPS) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Non-Invasive Prenatal Screening (NIPS) players cover Myriad Genetics, Illumina, Progenity, and Natera, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal Screening (NIPS) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Clinical Laboratories
Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2028
2.1.2 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Type
2.2.1 Trisomy 21
2.2.2 Trisomy 18
2.2.3 Trisomy 13
2.2.4 Sex Chromosome Aneuploidies
2.2.5 Others
2.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Type
2.3.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
2.4 Non-Invasive Prenatal Screening (NIPS) Segment by Application
2.4.1 Clinical Laboratories
2.4.2 Hospital
2.5 Non-Invasive Prenatal Screening (NIPS) Market Size by Application
2.5.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
3 Non-Invasive Prenatal Screening (NIPS) Market Size by Player
3.1 Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Players
3.1.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022)
3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Players (2020-2022)
3.2 Global Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-Invasive Prenatal Screening (NIPS) by Regions
4.1 Non-Invasive Prenatal Screening (NIPS) Market Size by Regions (2017-2022)
4.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
4.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
4.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022)
5.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
5.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022)
6.2 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
6.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-Invasive Prenatal Screening (NIPS) by Country (2017-2022)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) by Region (2017-2022)
8.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)
10.1.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)
10.1.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast
10.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)
10.2.1 United States Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.2.2 Canada Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.2.3 Mexico Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.2.4 Brazil Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)
10.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.2 Japan Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.3 Korea Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.4 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.5 India Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.6 Australia Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)
10.4.1 Germany Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.4.2 France Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.4.3 UK Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.4.4 Italy Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.4.5 Russia Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)
10.5.1 Egypt Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.5.2 South Africa Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.5.3 Israel Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.5.4 Turkey Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.5.5 GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.6 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Type (2023-2028)
10.7 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Information
11.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Myriad Genetics Main Business Overview
11.1.5 Myriad Genetics Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered
11.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Progenity
11.3.1 Progenity Company Information
11.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered
11.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Progenity Main Business Overview
11.3.5 Progenity Latest Developments
11.4 Natera
11.4.1 Natera Company Information
11.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Offered
11.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Natera Main Business Overview
11.4.5 Natera Latest Developments
11.5 Yourgene Health
11.5.1 Yourgene Health Company Information
11.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered
11.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Yourgene Health Main Business Overview
11.5.5 Yourgene Health Latest Developments
11.6 Roche Sequencing Solutions (RSS)
11.6.1 Roche Sequencing Solutions (RSS) Company Information
11.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered
11.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Roche Sequencing Solutions (RSS) Main Business Overview
11.6.5 Roche Sequencing Solutions (RSS) Latest Developments
11.7 Eurofins LifeCodexx GmbH
11.7.1 Eurofins LifeCodexx GmbH Company Information
11.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered
11.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Eurofins LifeCodexx GmbH Main Business Overview
11.7.5 Eurofins LifeCodexx GmbH Latest Developments
11.8 Labcorp
11.8.1 Labcorp Company Information
11.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered
11.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Labcorp Main Business Overview
11.8.5 Labcorp Latest Developments
11.9 PerkinElmer
11.9.1 PerkinElmer Company Information
11.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered
11.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 PerkinElmer Main Business Overview
11.9.5 PerkinElmer Latest Developments
11.10 Harmony
11.10.1 Harmony Company Information
11.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered
11.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Harmony Main Business Overview
11.10.5 Harmony Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Trisomy 21
Table 3. Major Players of Trisomy 18
Table 4. Major Players of Trisomy 13
Table 5. Major Players of Sex Chromosome Aneuploidies
Table 6. Major Players of Others
Table 7. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
Table 10. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
Table 13. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2020-2022)
Table 15. Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
Table 16. Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)
Table 21. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)
Table 23. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
Table 25. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
Table 27. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)
Table 29. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
Table 31. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
Table 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)
Table 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
Table 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Non-Invasive Prenatal Screening (NIPS)
Table 46. Key Market Challenges & Risks of Non-Invasive Prenatal Screening (NIPS)
Table 47. Key Industry Trends of Non-Invasive Prenatal Screening (NIPS)
Table 48. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Application (2023-2028)
Table 54. Myriad Genetics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 55. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 56. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Myriad Genetics Main Business
Table 58. Myriad Genetics Latest Developments
Table 59. Illumina Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 60. Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 61. Illumina Main Business
Table 62. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Illumina Latest Developments
Table 64. Progenity Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 65. Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 66. Progenity Main Business
Table 67. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Progenity Latest Developments
Table 69. Natera Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 70. Natera Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 71. Natera Main Business
Table 72. Natera Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Natera Latest Developments
Table 74. Yourgene Health Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 75. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 76. Yourgene Health Main Business
Table 77. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Yourgene Health Latest Developments
Table 79. Roche Sequencing Solutions (RSS) Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 80. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 81. Roche Sequencing Solutions (RSS) Main Business
Table 82. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Roche Sequencing Solutions (RSS) Latest Developments
Table 84. Eurofins LifeCodexx GmbH Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 85. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 86. Eurofins LifeCodexx GmbH Main Business
Table 87. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Eurofins LifeCodexx GmbH Latest Developments
Table 89. Labcorp Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 90. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 91. Labcorp Main Business
Table 92. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Labcorp Latest Developments
Table 94. PerkinElmer Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 95. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 96. PerkinElmer Main Business
Table 97. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. PerkinElmer Latest Developments
Table 99. Harmony Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 100. Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 101. Harmony Main Business
Table 102. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Harmony Latest Developments
List of Figures
Figure 1. Non-Invasive Prenatal Screening (NIPS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
Figure 7. Non-Invasive Prenatal Screening (NIPS) in Clinical Laboratories
Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Market: Clinical Laboratories (2017-2022) & ($ Millions)
Figure 9. Non-Invasive Prenatal Screening (NIPS) in Hospital
Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market: Hospital (2017-2022) & ($ Millions)
Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player in 2021
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
Figure 15. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
Figure 16. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
Figure 18. Americas Non-Invasive Prenatal Screening (NIPS) Value Market Share by Country in 2021
Figure 19. Americas Non-Invasive Prenatal Screening (NIPS) Consumption Market Share by Type in 2021
Figure 20. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
Figure 21. United States Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021
Figure 26. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
Figure 27. China Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2021
Figure 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
Figure 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
Figure 36. Germany Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
Figure 44. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 50. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 51. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 53. United States Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 54. Canada Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 57. China Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 58. Japan Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 59. Korea Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 61. India Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 62. Australia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 63. Germany Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 64. France Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 65. UK Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 66. Italy Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 67. Russia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 68. Spain Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 71. Israel Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets